Tyra Biosciences Inc. (TYRA)
TYRA trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$18.56
-5.31% on the day
Market cap
$1.3B
Small cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | TYRA on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001863127 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-09-15 |
| Latest annual report | 10-K | 2026-03-02 |
| Latest quarterly / interim | 10-Q | 2026-08-04 |
| Latest current report | 8-K | 2026-09-15 |
| Latest proxy | DEFA14A | 2026-04-17 |
Source: SEC EDGAR submissions feed, 425 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -8.8% |
| 1 month | -26.9% |
| 3 months | -41.2% |
| Year to date | -29.3% |
| 1 year | +29.5% |
| From 52-week high | -53.1% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| GHRS | GH Research PLC | $18.85 | -5.84% | $1.3B |
| NKTR | Nektar Therapeutics | $37.92 | -4.82% | $1.3B |
| SNDX | Syndax Pharmaceuticals Inc. | $13.95 | -15.71% | $1.2B |
| KARD | Kardigan Inc. | $12.97 | -9.62% | $1.2B |
| ANAB | AnaptysBio Inc. | $45.59 | -0.98% | $1.3B |
| OMER | Omeros Corporation | $18.88 | -3.82% | $1.4B |
| ORIC | Oric Pharmaceuticals Inc. | $11.31 | -4.23% | $1.2B |
| RAPP | Rapport Therapeutics Inc. | $28.99 | -3.85% | $1.4B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier